Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.8900
+0.0399 (4.69%)
At close: Nov 18, 2025, 4:00 PM EST
0.8900
0.00 (0.00%)
After-hours: Nov 18, 2025, 4:10 PM EST
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $75.77 million as of November 18, 2025. Its market cap has decreased by -71.56% in one year.
Market Cap
75.77M
Enterprise Value
-75.87M
1-Year Change
-71.56%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $75.77M, a decrease of -78.16%. That is a compound annual growth rate of -19.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 72.37M | -52.30% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | 987.90M | 288.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |